CanCell associated member, professor Terje Johansen is awarded King Olav V's cancer research prize for his world-leading research in selective autophagy.

Image may contain: Smile, Customer, Engineering, Retail, Event.

CanCell associated member professor Terje Johansen from UiT The Arctic University of Norway has been awarded King Olav V's cancer research prize for his groundbreaking work on selective autophagy. Autophagy is the process by which cells clear out waste and damaged components, and it plays a crucial role in protecting against diseases like Alzheimer's, Parkinson's, and cancer. While autophagy is desirable in many cases, it can also be hijacked by cancer cells to obtain the nutrients they need to survive. Johansen's research aims to block autophagy to starve cancer cells and improve cancer treatment outcomes. Although his work is challenging, he remains motivated to push forward and make a meaningful difference for cancer patients. Johansen's outstanding contributions to the field have earned him international recognition and a reputation as a true pioneer in his field.

Read more:

https://kreftforeningen.no/aktuelt/vi-hedrer-en-ekte-kreftpioner/

Published May 4, 2024 7:49 AM - Last modified May 4, 2024 7:49 AM